C07C233/64 - CPC Classification Index

ClassID:

92789 ⎘

C07C233/64 - CPC Classification

Classification description:

Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings

Sub-classes:

C07C233/65 » having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals 319
C07C233/66 » having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups 172
C07C233/67 » having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms 5
C07C233/76 » having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms 68
C07C233/77 » having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups 10
C07C233/81 » having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups 150

Recent Application in this class:

20250034121

COMPOUNDS AND THEIR USES AS GPR183 INHIBITORS

20230167050

PREPARATION OF AROMATIC CARBOXYAMIDES BY PALLADIUM-CATALYZED CARBONYLATION REACTION

20220396551

EBNA1 inhibitors and their method of use

20220040174

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

20210401836

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

20210395187

Method for treating a patient having a colon cancer

20210380526

Method for treating stomach cancer

20210340097

Method for making anti-cancer compounds

20210188765

Method for treating a patient having cancer

20210171439

Hepatitis B capsid assembly modulators

20200385337

Amide group-containing compounds and use for cancer treatment

20200385336

Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancer

20200199168

Class A GPCR-binding compound modifier

20200181078

EBNA1 inhibitors and their method of use

20200131129

FARNESOID X RECEPTOR AGONISTS AND USES THEREOF

20190381042

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

20190374541

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

20190144404

Process for producing organic compound

20180104243

Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction

20180093960

Method of inhibiting apolipoprotein-E expression while increasing expression of at least one of LDL-receptor protein or AbcA1 protein comprising administering a small compound

20180086699

EBNA1 inhibitors and their method of use

20170360956

Functionalized linear ligands and complexes thereof

20170152214

Insecticidal compounds

20170088507

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

20160289185

EBNA1 inhibitors and their method of use

20160058010

Pesticidal compositions and processes related thereto

20160037778

Pesticidal compositions and processes related thereto

20160029624

Insecticidal compounds

20150344414

Copolymer, and method for preparing a monomer used to form the copolymer

20150315146

USE OF SUBSTITUTED 1-(ARYL ETHYNYL)-, 1-(HETEROARYL ETHYNYL)-, 1-(HETEROCYCLYL ETHYNYL)- AND 1-(CYCLOALKENYLETHYNYL)-BICYCLOALKANOLS AS ACTIVE AGENTS AGAINST ABIOTIC PLANT STRESS

20150197502

Bis-acylated hydroxylamine derivatives

20150087759

Thermoplastic polymer composition

20150087758

Thermoplastic polymer composition

20150087757

Thermoplastic polymer composition

20140378461

Compounds

20140248236

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

20130023561

Facially amphiphilic polymers and oligomers and uses thereof

20120302781

Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents

20120208956

β-hydroxyalkylamides, a method for production of same and use of same

20110136827

Bis-acylated hydroxylamine derivatives

20110118825

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20110071612

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20110066251

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20110004014

Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents

20100292314

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20100240742

Anti-angiogenic nanoparticle compositions

20090197201

FLUOROSURFACTANTS

20090074830

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20090036517

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20080176807

Facially amphiphilic polymers and oligomers and uses thereof

20080166387

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20080020063

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20070298123

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

20070003630

Anti-angiogenic compositions and methods of use

20070003629

Anti-angiogenic compositions and methods of use

20060240113

Anti-angiogenic compositions and methods of use

20060127445

Anti-angiogenic compositions and methods of use

20060121117

Anti-angiogenic compositions and methods of use

20060041023

Facially amphiphilic polymers and oligomers and uses thereof

20050208137

Anti-angiogenic compositions and methods of use

20050123605

Anti-angiogenic compositions and methods of use

17355614

Pharmaceutical composition for treating cancer